we attempted a clinical trial to interrupt transmission of hepatitis b virus ( hbv ) infection from hepatitis b surface antigen ( hbsag ) positive and hepatitis be antigen ( hbsag ) positive mothers to their infants in taiwan .
C0019163
hepatitis b
C0019168
hbsag